On Friday NASDAQ: REGN soared 5.98% to $612.81. Optimistic investors gathered around the stock which totally traded with 6.7 million shares that is more than a daily average volume of 1.6 million shares. Last week’s first day was stressful for REGN fans as it fell sharply by $530.71. On the 27th of May, it started to grow steeply until the last trading day.
Several good news unveiled from Q1 2020 financial results which were recently announced by Regeneron Pharmaceuticals.
Q1 2020 Financial Results
Q1 2020 revenue fell to $1,828,200,000 from $2,169,500,000 quarterly. Eventually, its cost plummeted too, by $5.6 million. However, Q1 operating income soared to $700,100,000 resulting $624,60 net income. By almost $1 billion growth happened to total assets and equity. Conversely, total liabilities fell to $3.6 billion from $3.7 billion quarterly.
Currently, Regeneron Pharmaceuticals is valued by $68.955 billion market capitalization. 12-month based earnings per share are $19.91.
CEO and Editor in Chief.
Living in the era of dynamic tech change Asan decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring Finance) writing for technology and as well as finance has been one of the precious aspects of his life